Home › Trial NCT04648917
GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC)
- Trial IDNCT04648917
- StatusUnknown
- PhasePhase 3
- Study typeInterventional
- SponsorThe First Affiliated Hospital of Henan University of Science and Technology
- Enrollment80
- Start date2019-05-01
- ConditionsEsophagus Cancer, Stage III
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.